Coronavirus • 22 April, 2020

Germany approves first human trials for vaccine

2 timeviewed

A clinical test of a Covid-19 vaccine has been approved in Germany, the country’s Federal Institute for Vaccines has said.

In the first part of the trial, 200 healthy people between 18 and 55 will receive several variants of the vaccine.

The vaccine candidate was produced by biotech firm BioNTech, and is an RNA vaccine.

There are 86 teams across the world currently working to develop a Covid-19 vaccine, including a handful at the clinical trial stage.

Germany follows the UK in approving a human trial after health secretary Matt Hancock announced scientists at Oxford University will begin testing a vaccine on people this Thursday. 

Around 500 volunteers are expected to enrol in the programme by mid-May, with the British government pledging £20m to the research.

In China, early-stage human tests for two experimental vaccines were approved earlier this month, according to state media Xinhua.


Last news

Non-oil deficit to be gradually reduced

Kazakhstan • 14 May, 2020

Expired documents valid until July 10

Society • 14 May, 2020

Kazakhstan to open mosques from May 18

Kazakhstan • 14 May, 2020

Restrictive measures to be lifted in stages

Coronavirus • 12 May, 2020

30 people died from COVID-19 in Kazakhstan

Coronavirus • 06 May, 2020

Flood in Turkestan region in photos

Region • 06 May, 2020

All flood victims to be compensated

Region • 06 May, 2020

Similar news